Hemp growers sowing seeds of expansion
Future aims
Hempsoul produces 2 tons of CBD every year. It is destined for markets in 41 countries and for a wide range of uses, from anti-mite materials in luxury bedding to drugs to treat depression, insomnia and epilepsy.
"Our future aim is to definitely explore the use of CBD in medicines," Tian said.
In addition to CBD, companies are extracting Cannabidivarin, or CBDV, a nonpsychoactive cannabinoid that has gained attention in medical circles for its potential in the treatment of neurological conditions. So far, it has been studied less than its more famous counterparts, such as THC and CBD.
Meanwhile, even though it is sold overseas, CBD has not been authorized for consumption in China, which only permits its sale for use in cosmetics.
"As the global demand is booming, especially for related medical properties of CBD, I believe it is only a matter of time before China approves the compound for ingestion (either as a medicine or nutritional supplement)," Tian said.
Shi Wenzhi contributed to this story.
- China planning to raise age limit for blood donors, shorten the minimum interval
- Breakthrough in BMI tech aids patients
- Chinese technique for making ultrathin metal films named top 10 scientific breakthroughs
- Former senior political advisor of Sichuan sentenced to 14 years
- Beijing has undergone dramatic improvements since 2017's revamped development plans
- AI open alliance launched to pool resources for innovation and application
































